Terms: = Brain cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
433 results:
1. Microsurgical removal of supratentorial and cerebellar cavernous malformations: what has changed? A single institution experience.
Meneghelli P; Pasqualin A; Musumeci A; Pinna G; Berti PP; Polizzi GMV; Sinosi FA; Nicolato A; Sala F
J Clin Neurosci; 2024 May; 123():162-170. PubMed ID: 38581776
[TBL] [Abstract] [Full Text] [Related]
2. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
3. Effect of continuous hypertonic saline infusion on clinical outcomes in patients with traumatic brain injury.
Peng C; Chi L; Chen M; Peng L; Yang F; Shao L; Bo L; Jin Z
Neurosurg Rev; 2024 Feb; 47(1):78. PubMed ID: 38340147
[TBL] [Abstract] [Full Text] [Related]
4. Simulating photodynamic therapy for the treatment of glioblastoma using Monte Carlo radiative transport.
Finlayson L; McMillan L; Suveges S; Steele D; Eftimie R; Trucu D; Brown CTA; Eadie E; Hossain-Ibrahim K; Wood K
J Biomed Opt; 2024 Feb; 29(2):025001. PubMed ID: 38322729
[TBL] [Abstract] [Full Text] [Related]
5. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
6. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract] [Full Text] [Related]
7. National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection.
Kameda-Smith MM; Ragulojan M; Elliott C; Bliss L; Moore H; Sader N; Alsuwaihel M; Tso MK; Dakson A; Ajani O; Yarascavitch B; Fleming A; Mehta V; Aminnejad M; Farrokhyar F; Singh SK;
Childs Nerv Syst; 2024 May; 40(5):1339-1347. PubMed ID: 38279985
[TBL] [Abstract] [Full Text] [Related]
8. Molecular characteristics and improved survival prediction in a cohort of 2023 ependymomas.
Pohl LC; Leitheiser M; Obrecht D; Schweizer L; Wefers AK; Eckhardt A; Raffeld M; Sturm D; Pajtler KW; Rutkowski S; Fukuoka K; Ichimura K; Bockmayr M; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):24. PubMed ID: 38265522
[TBL] [Abstract] [Full Text] [Related]
9. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract] [Full Text] [Related]
10. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
11. PATIENT-RELATED FACTORS AND clinical MANAGEMENT outcomeS OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
12. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcomes of
Hansen KH; Johansen JS; Urbanska EM; Meldgaard P; Hjorth-Hansen P; Kristiansen C; Stelmach M; Santoni-Rugiu E; Ulhøi MP; Dydensborg AB; Dünweber C; Andersen JL
Acta Oncol; 2023 Dec; 62(12):1775-1783. PubMed ID: 37815923
[TBL] [Abstract] [Full Text] [Related]
14. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.
Simon J; Perez-Rivas LG; Zhao Y; Chasseloup F; Lasolle H; Cortet C; Descotes F; Villa C; Baussart B; Burman P; Maiter D; von Selzam V; Rotermund R; Flitsch J; Thorsteinsdottir J; Jouanneau E; Buchfelder M; Chanson P; Raverot G; Theodoropoulou M
Eur J Endocrinol; 2023 Sep; 189(3):372-378. PubMed ID: 37721395
[TBL] [Abstract] [Full Text] [Related]
15. Molecular Features of Resected Melanoma brain Metastases, clinical outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
16. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma - protocol for the Cavernomas: A Randomised Effectiveness (CARE) pilot trial.
Loan JJM; Bacon A; van Beijnum J; Bhatt P; Bjornson A; Broomes N; Bullen A; Bulters D; Cahill J; Chavredakis E; Colombo F; Danciut M; Digpal R; Edwards RJ; Ferguson L; Forsyth L; Fouyas I; Ganesan V; Grover P; Gurusinghe N; Hall PS; Harkness K; Harris LS; Hayton T; Helmy A; Holsgrove D; Hutchinson PJ; Israni A; Kinsella E; Lewis S; Majeed S; Mallucci C; Mukerji N; Nair R; Neilson AR; Papadopoulos MC; Radatz M; Rossdeutsch A; Raza-Knight S; Stephen J; Stoddart A; Teo M; Turner C; Wade J; Walsh D; White D; White P; Wildman J; Wroe Wright O; Uff C; Ushewokunze S; Vindlacheruvu R; Kitchen N; Al-Shahi Salman R;
BMJ Open; 2023 Aug; 13(8):e075187. PubMed ID: 37558454
[TBL] [Abstract] [Full Text] [Related]
17. Two- and three-dimensional endoscopic endonasal surgery of large and giant pituitary adenomas-outcome analysis of a series of 62 patients from a single pituitary center.
Loeschner D; Enciu A; Kellner G; Meyer A; Wallaschofski H; McLean ACL; Gerlach R
Neurosurg Rev; 2023 Jun; 46(1):150. PubMed ID: 37358696
[TBL] [Abstract] [Full Text] [Related]
18. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.
Kroh F; von Knebel Doeberitz N; Breitling J; Maksimovic S; König L; Adeberg S; Scherer M; Unterberg A; Bendszus M; Wick W; Bachert P; Debus J; Ladd ME; Schlemmer HP; Korzowski A; Goerke S; Paech D
Magn Reson Med; 2023 Oct; 90(4):1569-1581. PubMed ID: 37317562
[TBL] [Abstract] [Full Text] [Related]
19. clinical and imaging findings for the evaluation of large Rathke's cleft cysts and cystic craniopharyngiomas.
Yang CH; Wu CH; Lin TM; Chen ST; Tai WA; Yu KW; Luo CB; Lirng JF; Chang FC
Pituitary; 2023 Aug; 26(4):393-401. PubMed ID: 37227614
[TBL] [Abstract] [Full Text] [Related]
20. A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.
Mongiorgi S; De Stefano A; Ratti S; Indio V; Astolfi A; Casalin I; Pellagatti A; Paolini S; Parisi S; Cavo M; Pession A; McCubrey JA; Suh PG; Manzoli L; Boultwood J; Finelli C; Cocco L; Follo MY
Clin Epigenetics; 2023 Feb; 15(1):27. PubMed ID: 36803590
[TBL] [Abstract] [Full Text] [Related]
[Next]
